Related Funds
Fund Name | Location |
Ankr | California, San Francisco, United States |
Beijing Xingchen Wenhua Chuanmei | Beijing, China, Pinggu |
C-Bridge Capital | New York, New York, United States |
Cambia Health Solutions | Oregon, Portland, United States |
Huaou Equity Investment | China, Hangzhou, Zhejiang |
Invest In Visions | - |
JHC Ventures | - |
Kunming Venture Capital | China, Kunming, Yunnan |
New York Presbyterian Ventures | New York, New York, United States |
octopus | Arizona, Scottsdale, United States |
ProVen VCT | England, London, United Kingdom |
Satya Capital | England, London, United Kingdom |
Sazze | California, Santa Clara, United States |
SEGNEL Ventures | Central, Central Region, Singapore |
Sino Pacific Capital | China, Guangdong, Shenzhen |
Sintokogio | Aichi Prefecture, Japan, Nagoya |
Timken Foundation of Canton | - |
Valliance Capital | - |
WP Global Partners | Chicago, Illinois, United States |
WTT Investment | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MetWare | 02 Apr 2024 | Wuhan, Hubei, China | |||
Dearer Medical | 22 Jan 2024 | Minhang, Shanghai, China | |||
Maxone Semi | 01 Jun 2022 | Suzhou, Jiangsu, China | |||
Aucta Pharmaceuticals China | $15M | 04 Nov 2021 | Shanghai, China | ||
Kanghua Biotechnology | 26 Feb 2019 | Shanghai, China | |||
Shang Gong | $6M | 23 Aug 2018 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MetWare | 02 Apr 2024 | Wuhan, Hubei, China | |||
Dearer Medical | 22 Jan 2024 | Minhang, Shanghai, China | |||
Maxone Semi | 01 Jun 2022 | Suzhou, Jiangsu, China | |||
Aucta Pharmaceuticals China | $15M | 04 Nov 2021 | Shanghai, China | ||
Kanghua Biotechnology | 26 Feb 2019 | Shanghai, China | |||
Shang Gong | $6M | 23 Aug 2018 | Dongcheng District, Beijing, China |